A chimeric HS4-SAR insulator (IS2) that prevents silencing and enhances expression of lentiviral vectors in pluripotent stem cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Benabdellah, Karim ^a   Gutierrez Guerrero, Alejandra ^a   Cobo, Marién ^a   Muñoz, Pilar ^a   Martín, Francisco ^a  

^a PTS Granada   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ARTICLE; CELL LINE; CHIMERIC INSULATOR; CHROMATIN INSULATOR; CONTROLLED STUDY; DNA STRUCTURE; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HYPERSENSITIVE SITE 4; HYPERSENSITIVE SITE 4 MATRIX ATTACHMENT REGION INSULATOR; LONG TERMINAL REPEAT; MATRIX ATTACHMENT REGION; MOLECULAR STABILITY; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PROMOTER REGION; REGULATOR GENE; SPLEEN FOCUS FORMING VIRUS; TRANSGENE;

ANIMALS; BASE SEQUENCE; BETA-GLOBINS; CELL DIFFERENTIATION; CELL LINE; CHICKENS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ORDER; GENE SILENCING; GENETIC VECTORS; HEMATOPOIESIS; HUMANS; INSULATOR ELEMENTS; LENTIVIRUS; LOCUS CONTROL REGION; MOLECULAR SEQUENCE DATA; PLURIPOTENT STEM CELLS; TRANSGENES;

EID: 84896980415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084268     Document Type: Article

References (45)

1. Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, et al. (2009) The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119: 964-975.
2. Santilli G, Almarza E, Brendel C, Choi U, Beilin C, et al. (2011) Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells. Mol Ther 19: 122-132.
3. Mok HP, Javed S, Lever A (2007) Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Ther 14: 741-751. (Pubitemid 46585655)
4. Ellis J (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16: 1241-1246.
5. Senigl F, Auxt M, Hejnar J (2012) Transcriptional provirus silencing as a crosstalk of de novo DNA methylation and epigenomic features at the integration site. Nucleic Acids Res 40: 5298-5312.
6. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256. (Pubitemid 36077924)
7. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, et al. (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118: 3132-3142.
8. Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, et al. (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16: 198-204.
9. Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, et al. (2012) Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 20: 1014-1021.
10. Dravid G, Zhu Y, Scholes J, Evseenko D, Crooks GM (2011) Dysregulated gene expression during hematopoietic differentiation from human embryonic stem cells. Mol Ther 19: 768-781.
11. Poleshko A, Einarson MB, Shalginskikh N, Zhang R, Adams PD, et al. (2010) Identification of a functional network of human epigenetic silencing factors. J Biol Chem 285: 422-433.
12. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA (2003) High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21: 111-117. (Pubitemid 36120372)
13. Liew CG, Draper JS, Walsh J, Moore H, Andrews PW (2007) Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1521-1528. (Pubitemid 47106021)
14. Norrman K, Fischer Y, Bonnamy B, Wolfhagen Sand F, Ravassard P, et al. (2010) Quantitative comparison of constitutive promoters in human ES cells. PLoS One 5: e12413.
15. Chung JH, Bell AC, Felsenfeld G (1997) Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci U S A 94: 575-580.
16. Wei GH, Liu DP, Liang CC (2005) Chromatin domain boundaries: insulators and beyond. Cell Res 15: 292-300. (Pubitemid 41642885)
17. Neff T, Shotkoski F, Stamatoyannopoulos G (1997) Stem cell gene therapy, position effects and chromatin insulators. Stem Cells 15 Suppl 1: 265-271.
18. Rincon-Arano H, Furlan-Magaril M, Recillas-Targa F (2007) Protection against telomeric position effects by the chicken cHS4 beta-globin insulator. Proc Natl Acad Sci U S A 104: 14044-14049. (Pubitemid 350003332)
19. Barkess G, West AG (2012) Chromatin insulator elements: establishing barriers to set heterochromatin boundaries. Epigenomics 4: 67-80.
20. Emery DW, Yannaki E, Tubb J, Stamatoyannopoulos G (2000) A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A 97: 9150-9155. (Pubitemid 30626689)
21. Rivella S, Callegari JA, May C, Tan CW, Sadelain M (2000) The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol 74: 4679-4687. (Pubitemid 30237894)
22. Ryu BY, Evans-Galea MV, Gray JT, Bodine DM, Persons DA, et al. (2008) An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation. Blood 111: 1866-1875. (Pubitemid 351451495)
23. Li CL, Xiong D, Stamatoyannopoulos G, Emery DW (2009) Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator. Mol Ther 17: 716-724.
24. Urbinati F, Arumugam P, Higashimoto T, Perumbeti A, Mitts K, et al. (2009) Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3′LTR. Mol Ther 17: 1527-1536.
25. Uchida N, Washington KN, Lap CJ, Hsieh MM, Tisdale JF (2011) Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector. Mol Ther 19: 133-139.
26. Aker M, Tubb J, Groth AC, Bukovsky AA, Bell AC, et al. (2007) Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum Gene Ther 18: 333-343. (Pubitemid 46709345)
27. Arumugam PI, Urbinati F, Velu CS, Higashimoto T, Grimes HL, et al. (2009) The 3′ region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS One 4: e6995.
28. Hawley RG (2001) Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther 1: 1-17.
29. van Drunen CM, Sewalt RG, Oosterling RW, Weisbeek PJ, Smeekens SC, et al. (1999) A bipartite sequence element associated with matrix/scaffold attachment regions. Nucleic Acids Res 27: 2924-2930. (Pubitemid 29335714)
30. Agarwal M, Austin TW, Morel F, Chen J, Bohnlein E, et al. (1998) Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol 72: 3720-3728. (Pubitemid 28188670)
31. Dang Q, Auten J, Plavec I (2000) Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector. J Virol 74: 2671-2678. (Pubitemid 30117577)
32. Ramezani A, Hawley TS, Hawley RG (2003) Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 101: 4717-4724. (Pubitemid 36857727)
33. Park F, Kay MA (2001) Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 4: 164-173. (Pubitemid 32851279)
34. Klehr D, Schlake T, Maass K, Bode J (1992) Scaffold-attached regions (SAR elements) mediate transcriptional effects due to butyrate. Biochemistry 31: 3222-3229.
35. Emery DW (2011) The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. Hum Gene Ther 22: 761-774.
36. Arumugam PI, Scholes J, Perelman N, Xia P, Yee JK, et al. (2007) Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol Ther 15: 1863-1871. (Pubitemid 47434195)
37. Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, et al. (2012) Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 20: 1014-1021.
38. Giannakopoulos A, Stavrou EF, Zarkadis I, Zoumbos N, Thrasher AJ, et al. (2009) The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences. J Mol Biol 387: 1239-1249.
39. Yannaki E, Tubb J, Aker M, Stamatoyannopoulos G, Emery DW (2002) Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors. Mol Ther 5: 589-598. (Pubitemid 34546089)
40. Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, et al. (2008) Gene therapy for Chonic Granulomatous Disease: Current status of the german clinical study. Human Gene Therapy 19: 1097.
41. Cortes JL, Sanchez L, Ligero G, Gutierrez-Aranda I, Catalina P, et al. (2009) Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos. Hum Reprod 24: 1844-1851.
42. Munoz P, Toscano MG, Real PJ, Benabdellah K, Cobo M, et al. (2012) Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors. PLoS One 7: e39091.
43. Benabdellah K, Cobo M, Munoz P, Toscano MG, Martin F (2011) Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines. PLoS One 6: e23734.
44. Toscano MG, Frecha C, Benabdellah K, Cobo M, Blundell M, et al. (2008) Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein. Hum Gene Ther 19: 179-197. (Pubitemid 351271509)
45. Ji J, Vijayaragavan K, Bosse M, Menendez P, Weisel K, et al. (2008) OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells 26: 2485-2495.